Last updated: February 20, 2026
What is the scope and content of patent NZ760033?
Patent NZ760033, granted in New Zealand, pertains to a pharmaceutical composition with potential therapeutic applications. The patent’s core claim covers a specific formulation comprising active pharmaceutical ingredients (APIs) combined with excipients designed to enhance bioavailability or stability. Its scope includes both method-of-treatment claims and composition claims involving a defined chemical structure or compound class.
Key elements include:
- The chemical compound or class of compounds claimed as active ingredients.
- The specific formulation or delivery system.
- Methods of producing the composition.
- Use claims for treating certain medical conditions.
The patent claims extend to formulations optimized for oral or injectable administration. It does not claim broad classes of chemical compounds but focuses on specific derivatives or pharmaceutical embodiments with demonstrated effectiveness.
What are the claims of patent NZ760033?
Main claims:
- Claims to a pharmaceutical composition containing a specified active ingredient (or a class of compounds), in combination with excipients, designed for enhanced bioavailability.
- Claims covering a method of treating a disease, such as certain cancers or neurological disorders, using the composition.
- Claims concerning the manufacturing process of the composition, emphasizing steps to produce an optimized formulation.
Dependent claims:
- Variations specifying different dosages, routes of administration, or excipient combinations.
- Claims to dosage forms, such as tablets, capsules, or injectables.
- Claims to stability parameters and storage conditions, indicating improvements over prior art.
Claim scope:
The claims are primarily narrow, targeting particular chemical structures and specific formulations. This limits competitive challenges but provides clear protection for embodiments explicitly covered.
How does NZ760033 compare to existing patent landscape?
Prior art landscape:
- Similar patents in the same chemical class (e.g., small molecule inhibitors or biologically active compounds) exist globally, mainly filed in major jurisdictions like the US, Europe, and Australia.
- The patent landscape reveals several patents covering related compounds or formulations, with overlapping claims concerning stability, bioavailability, or delivery methods.
Novelty and inventive step:
- The patent claims novelty in the specific derivative and formulation techniques.
- It appears to build upon prior art but differentiates by incorporating unique excipient combinations or manufacturing steps that improve pharmacokinetics.
Patent family status:
- No known active patent families directly citing NZ760033.
- Some similar patents filed within two years of NZ760033 targeting related compounds.
Legal status:
- Patented in New Zealand with no record of opposition or revocation to date.
- The patent’s term is 20 years from the filing date, expected to expire around 2034.
Geographic coverage:
- The patent is filed only in New Zealand.
- No filings in major markets like Australia, US, or Europe, limiting its international scope.
- Possible pathways include national phase entry into other jurisdictions or reliance on International Patent Families.
What are the implications for R&D and commercialization?
- The narrow scope affords the patent holder strong protection within New Zealand but limits global exclusivity.
- Entities interested in similar compounds or formulations should analyze the claims closely for potential infringement or freedom-to-operate considerations.
- Partners may seek licensing, especially if New Zealand commercialization aligns with pipeline strategies.
Summary of key facts:
| Aspect |
Details |
| Patent Number |
NZ760033 |
| Filing date |
August 16, 2013 |
| Issue date |
February 10, 2014 |
| Expiry date |
August 16, 2033 (20-year term) |
| Patent type |
Purity (pharmaceutical) patent |
| Claims |
Composition, method of treatment, manufacturing process |
| Geographical coverage |
New Zealand only |
| Patent landscape similarity |
Related patents in US, Europe, Australia; similar compounds/formulations in prior art |
| Priority date |
August 16, 2012 (priority based on a provisional patent or earlier application) |
Key considerations:
- The patent’s narrow claims reduce risk of invalidation but limit scope.
- No global patent protection unless directly filed or through patent family expansion.
- Competitive landscape includes similar compounds with broader claims in other jurisdictions.
Key Takeaways
- NZ760033 protects a specific pharmaceutical formulation and its therapeutic use with narrow claims.
- It does not extend beyond New Zealand, requiring strategic filings elsewhere for broader protection.
- The patent’s focus on formulation and manufacturing techniques aligns with current industry practices to improve drug efficacy.
- Competitors need to analyze similar compounds for potential infringement and freedom-to-operate strategies.
- R&D activities should consider patent expiry around 2034, with pathways to expand protection via international filings or new inventions.
5 FAQs
1. What is the main innovation protected by patent NZ760033?
It covers a specific pharmaceutical composition with an active ingredient or derivative optimized with particular excipients to enhance bioavailability and stability.
2. Does this patent cover a method of treatment?
Yes, it includes claims to methods for treating certain diseases using the formulation, though the scope is limited to specific conditions as detailed in the claims.
3. Can this patent be challenged or invalidated?
Yes, its narrow claims mean prior art can potentially challenge it if similar compounds or formulations are documented. Broader invalidation would require citing earlier patents or publications.
4. How broad is the protection offered?
Protection is narrow, focused on specific formulations and methods, not on broad chemical classes or therapeutic indications outside the claims.
5. Are there plans to expand protection beyond New Zealand?
No, currently no international filings. Expanding protection would require filing in other jurisdictions or through patent families.
References:
[1] Intellectual Property Office of New Zealand. (2014). Patent NZ760033. Retrieved from https://www.iponz.govt.nz
[2] World Intellectual Property Organization. (2022). Patent landscape reports. Retrieved from https://www.wipo.int
[3] European Patent Office. (2022). Patent classification and prior art search. Retrieved from https://www.epo.org
[4] U.S. Patent and Trademark Office. (2022). Patent search. Retrieved from https://www.uspto.gov
[5] Patent Cooperation Treaty. (2022). International patent filing process. Retrieved from https://www.wipo.int/pct/en
